Related references
Note: Only part of the references are listed.A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults
Daniel Drazan et al.
VACCINE (2022)
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older
Johannes Beeslaar et al.
VACCINE (2022)
National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021
Cassandra Pingali et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and Young Adults
Jiří Beran et al.
mSphere (2021)
Vaccines against Meningococcal Diseases
Mariagrazia Pizza et al.
MICROORGANISMS (2020)
A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
Jamie Findlow et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence
Jamie Findlow et al.
FUTURE MICROBIOLOGY (2019)
Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis
Bing Wang et al.
VACCINE (2019)
Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis
Ali Purmohamad et al.
MICROBIAL PATHOGENESIS (2019)
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine
John L. Perez et al.
EXPERT REVIEW OF VACCINES (2018)
The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci
Shannon L. Harris et al.
VACCINE (2018)
Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents
Timo Vesikari et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2016)
The value of childhood combination vaccines: From beliefs to evidence
Khaled Maman et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Meningococcal disease: Clinical presentation and sequelae
David Pace et al.
VACCINE (2012)
Meningococcal carriage by age: a systematic review and meta-analysis
Hannah Christensen et al.
LANCET INFECTIOUS DISEASES (2010)
Meningococcal surrogates of protection - serum bactericidal antibody activity
R Borrow et al.
VACCINE (2005)